Increasing international migration and changing immigrant populations in OECD countries make international comparable data on migrant populations essential. These data should be updated regularly to capture a detailed picture of migrant populations. This document presents the first results of...

This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada’s achievements in meeting a range of...

This paper examines aspects of the policy environment and market characteristics of the Swedish pharmaceutical sector, assesses the degree to which Sweden has achieved certain policy goals, and puts forth some key findings and conclusions. Thanks to low mark-ups in the distribution chain and no...

This paper examines aspects of the policy environment and market characteristics of the Swiss pharmaceutical sector, and assesses the degree to which Switzerland has achieved certain policy goals. In Switzerland, pharmaceutical spending has not been growing faster than health expenditure as a...

Increasing international mobility makes international comparable data even more important, to depict global migration patterns and its characteristics, not only in receiving countries but also in origin countries. This paper provides a detailed picture of immigrant and emigrant populations...